Skip navigation
Speakers

Benchmark with International Peers to Gauge RBM Performance, Efficiencies, Implementation and Technologies

September 13-14, 2018
  • London, United Kingdom

Lisa Berdan
Director, Global Megatrials
Duke Clinical Research Institute

Lukasz Bojarski, PhD
Associate Director, Centralised Monitoring
AstraZeneca

Gavin Boodoo
Risk Based Monitoring Consultant
Roche

Nurcan Coskun
Global Risk Based Monitoring Program &
Technology Solutions Manager
Medtronic

Carolina Errobidart
Central Monitor
Bristol-Myers Squibb

Anna Herradon
Associate Director, Site Monitoring Manager, Bristol-Myers Squibb;
Country Lead, TransCelerate Spain

Carol Knott
Head of Monitoring and Nurse Training
University of Oxford

Amy Loescher
Head, Outsourcing Partner Management,
Risk Management Central Monitoring
Janssen

Marcel Merfort, PhD
Business Application Manager, Clinical Operations,
ystem & Process Excellence
Roche

Monika Mörsch
Team Lead, Risk Based Quality Management, Risk Based Monitoring
Boehringer-Ingelheim

Thomas Naeschen
Clinical Project Manager
Boston Scientific

Morten Thorup Pedersen
Risk Based Monitoring Specialist
Novo Nordisk

Julie Solbjerg Appel
Clinical Data Surveillance Specialist
Novo Nordisk

Lisa Berdan
Director, Global Megatrials
Duke Clinical Research Institute

Lukasz Bojarski, PhD
Associate Director, Centralised Monitoring
AstraZeneca

Gavin Boodoo
Risk Based Monitoring Consultant
Roche

Nurcan Coskun
Global Risk Based Monitoring Program &
Technology Solutions Manager
Medtronic

Carolina Errobidart
Central Monitor
Bristol-Myers Squibb

Anna Herradon
Associate Director, Site Monitoring Manager, Bristol-Myers Squibb;
Country Lead, TransCelerate Spain

Carol Knott
Head of Monitoring and Nurse Training
University of Oxford

Amy Loescher
Head, Outsourcing Partner Management,
Risk Management Central Monitoring
Janssen

Marcel Merfort, PhD
Business Application Manager, Clinical Operations,
ystem & Process Excellence
Roche

Monika Mörsch
Team Lead, Risk Based Quality Management, Risk Based Monitoring
Boehringer-Ingelheim

Thomas Naeschen
Clinical Project Manager
Boston Scientific

Morten Thorup Pedersen
Risk Based Monitoring Specialist
Novo Nordisk

Julie Solbjerg Appel
Clinical Data Surveillance Specialist
Novo Nordisk